Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study Meeting Abstract


Authors: Álvarez, E.; Brady, W.; Walker, J.; Rotmensch, J.; Zhou, X.; Kendrick, J.; Yamada, S.; Aghajanian, C.
Abstract Title: Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
Meeting Title: 43rd Annual Meeting of the Society of Gynecologic Oncology (SGO)
Journal Title: Gynecologic Oncology
Volume: 125
Issue: Suppl. 1
Meeting Dates: 2012 Mar 24-27
Meeting Location: Austin, TX
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2012-03-01
Start Page: S17
Language: English
ACCESSION: WOS:000303227600042
DOI: 10.1016/j.ygyno.2011.12.041
PROVIDER: wos
PUBMED: 22416290
Notes: - Meeting Abstract: 40 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors